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Olestra — Fat Substitute Approved by 
FDA in January 1996
NF 96-306
by Jan Massey, Dietetic Intern, University of Nebraska Medical Center
Linda Boeckner, Extension Nutrition Specialist
On January 24, 1996, after $200 million and 
25 years of study by Procter & Gamble, the Food 
and Drug Administration (FDA) approved another 
fat substitute called Olestra. At this time, the prod-
uct is approved for use only in snack foods such 
as potato, corn and tortilla chips, and crackers. The 
company plans to use the fat substitute under the 
trade name Olean.
Chemically, Olestra is formed by bonding 
sucrose (table sugar) and six to eight fatty acid 
molecules together. The resulting combination has 
properties such as taste, texture, and the ability to 
withstand high cooking temperatures similar to 
those of a naturally occurring fat. Unlike naturally 
occurring fat, Olestra provides no calories because 
it passes through the digestive tract but is not ab-
sorbed into the body.
Some consumers and health organizations 
have raised concern about Olestra because of 
potential side effects. Olestra can cause abdominal 
cramping, bloating, flatulence, and loose stools. 
However, with typical consumption patterns, most 
people will experience no adverse gastrointes- 
tinal effects.
Olestra also prevents the absorption of the 
fat-soluble vitamins A, D, E and K. The FDA has 
determined the impact on carotenoids, which are 
precursors to vitamin A, is not likely to be sig - 
nif cant. To address this problem, the manufac- 
turer is adding enough of the fat-soluble vitamins 
back into olestra-based foods to make up for the 
losses.
As a food additive, Olestra falls under the 
federal Food, Drug and Cosmetic Act of 1938 and 
the food additives amendment of 1958. According 
to these laws, a food additive can be approved if 
it carries a reasonable certainty of no harm when 
used as intended. Since the food manufacturer 
has corrected the nutrient-blocking effect by forti-
fying snack foods and the gastrointestinal problems 
were not deemed to be signifcant, the product has 
been approved. The FDA is requiring all snacks 
containing Olestra to carry the following state- 
ments as a part of the nutrition label:
This product contains Olestra. Olestra may 
cause abdominal cramping and loose stools. 
Olestra inhibits the absorption of some vita- 
mins and other nutrients. Vitamins A, D, E and K 
have been added.
Natural fats do have many roles in the diet, 
but too much fat can be harmful. Nearly a third of 
all Americans are obese. The combination of high 
fat diets, extra weight, and too little exercise has 
been linked to heart disease, high blood pressure, 
diabetes and several types of cancer. For these 
reasons, many Americans are trying to reduce their 
fat intake and are doing so by consuming more of 
the reduced-fat products on the market.
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The benefts claimed for Olestra are taste 
retention combined with fat reduction. The over- 
all impression is that it can help people lose 
weight. Since Olestra has been approved for use 
in commercial snack foods only, it may not have 
much effect on the national waistline and health 
if people eat more chips and other high-fat foods 
to compensate for lost calories. Olestra is not 
available to consumers as an ingredient to be used 
in their own food preparation.
On-going studies are still being conducted 
with Olestra to determine any unknown con - 
sequences of its use. Regardless of the potential 
benefts of using this new fat replacer, it will still 
pay to watch total fat intake, eat a variety of foods 
from all food groups, and eat in moderation for 
your best bet for weight management and a life- 
time of good health.
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